Literature DB >> 6625088

Cervical node metastasis of occult origin.

R H Spiro, G DeRose, E W Strong.   

Abstract

This study reviewed a 12 year experience with 132 patients who were treated for metastatic carcinoma of the cervical lymph nodes with no apparent primary tumor. Using radical neck dissection as the main treatment modality, a 5 year survival of 50 percent was achieved in 79 patients with epidermoid carcinoma. Survival varied significantly depending on the extent of the tumor in the neck. It was 74 percent in those with stage N1 disease compared with 41 percent in patients with N2 or N3 disease. Recurrence in the neck, the major reason for treatment failure, can probably be reduced by more aggressive use of adjunctive radiotherapy. Primary tumors were identified after therapy in only 15 percent of these patients, and this appeared to have relatively little impact on the outcome. Irradiation and chemotherapy were the preferred treatment modalities in 29 patients with metastatic adenocarcinoma of occult origin. All but one patient died within 29 months. A 53 percent 5 year survival was achieved in 13 patients with anaplastic or undifferentiated carcinoma. Radical neck dissection was employed in 11 patients with melanoma. No primary tumor was ever identified in this group and only one patient remained alive and well after 5 years.

Entities:  

Mesh:

Year:  1983        PMID: 6625088     DOI: 10.1016/0002-9610(83)90227-1

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  10 in total

Review 1.  Management of cervical metastasis.

Authors:  Eric J Lentsch
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

2.  Neck mestastasis from unknown origin-results of planned primary surgery and post-operative radiation therapy.

Authors:  A M Shenoy; H Ashok; A V Hari Prasad; K Nanjundappa; S Ravi; S Sathish Kumar; B K Reddy; P S Prabhakaran
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2001-07

3.  Diagnosis and management of carcinoma of unknown primary in the head and neck.

Authors:  Wolfgang J Issing; Behsad Taleban; Stefan Tauber
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-04-09       Impact factor: 2.503

4.  The management of neck nodes in head and neck cancer: a surgeon's view.

Authors:  R H Spiro
Journal:  Bull N Y Acad Med       Date:  1985-09

5.  Melanoma with unknown primary: report and analysis of 24 patients.

Authors:  Rita Clerico; Ugo Bottoni; Giovanni Paolino; Marina Ambrifi; Paola Corsetti; Valeria Devirgiliis; Stefano Calvieri
Journal:  Med Oncol       Date:  2012-03-30       Impact factor: 3.064

6.  Treatment of cervical lymph node metastasis from an unknown primary tumor, with a review of the literature.

Authors:  H J van der Planken; R M Tiwari; A B Karim
Journal:  Strahlenther Onkol       Date:  1997-03       Impact factor: 3.621

7.  [Therapy pf cervical lymph node metastases of unknown primary tumor].

Authors:  M J Kirschner; R Fietkau; F Waldfahrer; H Iro; R Sauer
Journal:  Strahlenther Onkol       Date:  1997-07       Impact factor: 3.621

8.  Cervical metastasis from the unknown primary tumor.

Authors:  A L Oen; M F de Boer; W C Hop; P Knegt
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

9.  The management of a neck mass: presenting feature of an asymptomatic head and neck primary malignancy?

Authors:  M Barakat; L M Flood; V H Oswal; R W Ruckley
Journal:  Ann R Coll Surg Engl       Date:  1987-07       Impact factor: 1.891

10.  Cost-effectiveness in the diagnosis and treatment of carcinoma of unknown primary origin.

Authors:  M N Levine; M F Drummond; R J Labelle
Journal:  CMAJ       Date:  1985-11-15       Impact factor: 8.262

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.